lisinopril and Fatty-Liver

lisinopril has been researched along with Fatty-Liver* in 3 studies

Trials

2 trial(s) available for lisinopril and Fatty-Liver

Article	Year
[Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors]. Kardiologiia, 2009, Volume: 49, Issue:3 It is necessary to take into account presence of concomitant pathology while prescribing hypotensive therapy to patients with arterial hypertension (AH). Hydrophilic angiotensin converting enzyme inhibitors (ACEI) (lisinopril) which are not metabolized in the liver are theoretically safest in liver cirrhosis. We have examined and treated 180 patients with AH and assessed efficacy and tolerability of ACEI lisinopril and enalapril with consideration of their pharmacokinetic peculiarities in patients with various severity of involvement of the liver (steatosis or cirrhosis). Advantage of hypotensive effect of lisinopril (which required no biotransformation in the liver) over enalapril based on its pharmacokinetic properties has been demonstrated. Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Enalapril; Fatty Liver; Female; Humans; Hypertension; Lisinopril; Liver Cirrhosis; Male; Middle Aged	2009
[ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Enalapril; Fatty Liver; Female; Humans; Hypertension; Lisinopril; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Treatment Outcome	2007

Article

Year

[Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors].

Kardiologiia, 2009, Volume: 49, Issue:3

It is necessary to take into account presence of concomitant pathology while prescribing hypotensive therapy to patients with arterial hypertension (AH). Hydrophilic angiotensin converting enzyme inhibitors (ACEI) (lisinopril) which are not metabolized in the liver are theoretically safest in liver cirrhosis. We have examined and treated 180 patients with AH and assessed efficacy and tolerability of ACEI lisinopril and enalapril with consideration of their pharmacokinetic peculiarities in patients with various severity of involvement of the liver (steatosis or cirrhosis). Advantage of hypotensive effect of lisinopril (which required no biotransformation in the liver) over enalapril based on its pharmacokinetic properties has been demonstrated.

Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Enalapril; Fatty Liver; Female; Humans; Hypertension; Lisinopril; Liver Cirrhosis; Male; Middle Aged

2009

[ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:4

Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Enalapril; Fatty Liver; Female; Humans; Hypertension; Lisinopril; Liver Cirrhosis; Male; Middle Aged; Peptic Ulcer; Treatment Outcome

2007

Other Studies

1 other study(ies) available for lisinopril and Fatty-Liver

Article	Year
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 25-2004. A 49-year-old woman with severe obesity, diabetes, and hypertension. The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7 Topics: Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Liver; Female; Gastric Bypass; Humans; Hypertension; Lisinopril; Liver; Middle Aged; Nutritional Status; Obesity; Obesity, Morbid; Sciatica; Sleep Apnea Syndromes	2004

Article

Year

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 25-2004. A 49-year-old woman with severe obesity, diabetes, and hypertension.

The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7

Topics: Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Liver; Female; Gastric Bypass; Humans; Hypertension; Lisinopril; Liver; Middle Aged; Nutritional Status; Obesity; Obesity, Morbid; Sciatica; Sleep Apnea Syndromes

2004